In line with our results, recent studies described the beneficial activity of a modified citrus pectin in the inhibition of the NLRP3 inflammasome and NF-kB pathway activation in microglia during cerebral ischemia [40]. The gene discussed is NLRP3; the disease is Cerebral ischemia.